Polymorphism of the human TNF-α promoter - Random variation or functional diversity?

Molecular Immunology

Volumn 36, Issue 15-16, 1999, Pages 1017-1027

  Allen, Ruth D ^a  

^a INDIANA UNIVERSITY   (United States)

Author keywords

Cytokines; Immunogenetics; Polymorphism; TNF ; Tumor necrosis factor

Indexed keywords

ARTICLE; DISEASE PREDISPOSITION; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC POLYMORPHISM; GENETIC TRANSCRIPTION; HUMAN; IMMUNOGENETICS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION;

ALLELES; AUTOIMMUNE DISEASES; BASE SEQUENCE; DNA; GENE FREQUENCY; GENOTYPE; HUMANS; MOLECULAR SEQUENCE DATA; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); TRANSCRIPTION, GENETIC; TUMOR NECROSIS FACTOR-ALPHA; VARIATION (GENETICS);

EID: 0033368180     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0161-5890(99)00127-3     Document Type: Article

References (53)

1. Amiot F., Bousssadia O., Cases S., Fitting C., Lebastard M., Cavaillon J.M., Milon G., Dautry F. Mice heterozygous for a deletion of the tumor necrosis factor-α and lymphotoxin-α genes: biological importance of a non-linear response of tumor necrosis factor-α to gene dosage. Eur. J. Immunol. 27:1997;1035-1042.
2. Bailly S., Di Giovine F.S., Blakemore A.I., Duff G.W. Genetic polymorphism of human interleukin-1 alpha. Eur. J. Immunol. 23:1993;1240-1245.
3. Bioque G., Crusius J.B.A., Koutroubakis I., Bouma G., Kostense P.J., Neuwissen S.G., Peña A.S. Allelic polymorphism in interleukin-1 beta and interleukin-1 receptor antagonist (IL-1Ra) genes in inflammatory bowel disease. Clin. Exp. Immunol. 102:1995;379-383.
4. Bouma G., Crusius J.B.A., Pool M.O., Kolkman J.J., von Blomberg B.M.E., Kostense P.J., Giphart M.J., Schreuder G.M.Th, Meuwissen S.G.M., Peña A.S. Secretion of tumour necrosis factor α and lymphotoxin α in relation to polymorphisms in the TNF genes and HLA-DR alleles. Relevance for inflammatory bowel disease. Scand. J. Immunol. 43:1996;456-463.
5. Braun N., Michel U., Ernst B.P., Metzner R., Bitsch A., Weber F., Reickmann P. Gene polymorphism at position -308 of the tumor-necrosis-factor-α (TNF-α) in multiple sclerosis and its influence on the regulation of TNF-α production. Neurosci. Lett. 215:1996;75-78.
6. Brinkman B.M., Giphart M.J., Verhoef A., Kaijzel E.L., Naipal A.M., Daha M.R., Breedveld F.C., Verweij C.L. Tumor necrosis factor alpha -308 gene variants in relation to major histocompatibility complex alleles and Felty's syndrome. Hum. Immunol. 41:1994;259-266.
7. Brinkman B.M., Kaijzel E.L., Huizinga T.W.J., Giphart M.J., Breedveld F.C., Verweij C.L. Detection of a C-insertion polymorphism within the human tumor necrosis factor alpha (TNFA) gene. Hum. Genet. 96:1995;493.
8. Brinkman B.M.N., Zuijdgeest D., Kaijzel E.L., Breedveld F.C., Verweij C.L. Relevance of the tumor necrosis factor alpha (TNFα) -308 promoter polymorphism in TNFα gene regulation. J. Inflamm. 46:1996;32-41.
9. Brinkman B.M., Huizinga T.W., Kurban S.S., van der Velde E.A., Schreuder G.M., Hazes J.M., Breedveld F.C., Verweij C.L. Tumour necrosis factor alpha gene polymorphisms in rheumatoid arthritis: association with susceptibility to, or severity of, disease? Br. J. Rheumatol. 36:1997;516-521.
10. Cabrera M., Shaw M.A., Sharples C., Williams H., Castes M., Convit J., Blackwell J.M. Polymorphism in tumor necrosis factor genes associated with mucocutaneous leishmaniasis. J. Exp. Med. 182:1995;1259-1264.
11. Chen C.-J., Yen J.-H., Tsai W.-C., Wu C.-S., Chiang W., Tsai J.-J., Liu H.-W. The TNF2 allele does not contribute towards susceptibility to systemic lupus erythematosus. Immunol. Lett. 55:1997;1-3.
12. Conway D.J., Holland M.J., Bailey R.L., Campbell A.E., Mahdi O.S., Jennings R., Mbena E., Mabey D.C. Scarring trachoma is associated with polymorphism in the tumor necrosis factor alpha (TNF-α) gene promoter and with elevated TNF-α levels in tear fluid. Infect. Immun. 65:1997;1003-1006.
13. D'Alfonso S., Richiardi P.M. A polymorphism variation in a putative regulation box of the TNFa promoter region. Immunogenet. 39:1994;150-154.
14. Danis V.A., Millington M., Hyland V., Lawford R., Huang Q., Grennan D. Increased frequency of the uncommon allele of a tumour necrosis factor alpha gene polymorphism in rheumatoid arthritis and systemic lupus erythematosus. Dis. Mark. 12:1994;127-133.
15. Deng G.Y., Maclaren N.K., Huang H.S., Zhang L.P., She J.X. No primary association between the 308 polymorphism in the tumor necrosis factor alpha promoter region and insulin-dependent diabetes mellitus. Hum. Immunol. 45:1996;137-142.
16. Fishman D., Faulds G., Jeffery R., Mohamed-Ali V., Yudkin J.S., Humphries S., Woo P. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J. Clin. Invest. 102:1998;1369-1376.
17. Fong K.Y., Howe H.S., Tin S.K., Boey M.L., Feng P.H. Polymorphism of the regulatory region of tumour necrosis factor alpha gene in patients with systemic lupus erythematosus. Ann. Acad. Med. Singapore. 25:1996;90-93.
18. Fraile A., Nieto A., Beraun Y., Vinasco J., Mataran L., Martin J. Tumor necrosis factor gene polymorphisms in ankylosing spondylitis. Tissue Antigens. 51:1998;386-390.
19. Freeburn R.W., Gale R.E., Wagner H.M., Linch D.C. The beta subunit common to the GM-CSF, IL-3 and IL-5 receptors is highly polymorphic but pathogenic point mutations in patients with acute myeloid leukemia (AML) are rare. Leukemia. 10:1996;123-129.
20. Hamann A., Mantzoros C., Vidal-Puig A., Flier J.S. Genetic variability in the TNF-polymorphism promoter is not associated with type II diabetes mellitus (NIDDM). Biophys. Bioch. Res. Comm. 211:1995;833-839.
21. He B., Navikas V., Lundahl J., Soderstrom M., Hillert J. Tumor necrosis factor alpha-308 alleles in multiple sclerosis and optic neuritis. J. Neuroimmunol. 63:1995;143-147.
22. Higuchi T., Seki N., Kamizono S., Yamada A., Kimura A., Kato H., Itoh K. Polymorphism of the 5′-flanking region of the human tumor necrosis factor (TNF)-α gene in Japanese. Tissue Antigens. 51:1998;605-612.
23. Hohler T., Kruger A., Gerken G., Schneider P.M., Meyer zum Bruschenefelde K.H., Rittner C. A tumor necrosis factor-alpha (TNF-alpha) promoter polymorphism is associated with chronic hepatitis B infection. Clin. Exp. Immunol. 111:1998;579-582.
24. Hohler T., Kruger A., Gerken G., Schneider P.M., Meyer zum Buschenefelde K.H., Rittner C. Tumor necrosis factor alpha promoter polymorphism at position -238 is associated which chronic active hepatitis C infection. J. Med. Virol. 54:1998;173-177.
25. Huizinga T.W.J., Westendorp R.G.J., Bollen E.L.E.M., Keijsers V., Brinkman B.M.N., Langermans J.A.M., Breedveld F.C., Verweij C.L., van de Gaer L., Dams L., Crusius J.B.A., Garcia-Gonzalez A., van Oosten B.W., Polman C.H., Peña A.S. TNF-α promoter polymorphisms, production and susceptibility to multiple sclerosis in different groups of patients. J. Neuroimmunol. 72:1997;149-153.
26. Jacob C.O., Fronek Z., Lewis G.D., Koo M., Hansen J.A., McDevitt H.O. Heritable major histocompatibility complex class II-associated differences in production of tumor necrosis factor alpha: relevance to genetic predisposition to systemic lupus erythematosus. Proc. Natl. Acad. Sci. USA. 87:1990;1233-1237.
27. Jeong M.C., Navani A., Oksenberg J.R. Limited allelic polymorphism in the human interleukin-3 gene. Mol. Cell. Probes. 12:1998;49-53.
28. John S., Turner D., Donn R., Sinnott P., Worthington J., Ollier W.E., Hutchinson IV, Hajeer A.H. Two novel biallelic polymorphisms in the IL-2 gene. Eur. J. Immunogen. 25:1998;419-420.
29. Kaijzel E.L., van Krugten M.V., Brinkman B.M.N., Huizinga T.W.J., van der Straaten T., Hazes J.M.W., Ziegler-Heitbrock H.W.L., Nedospasov S.A., Breedvold F.C., Verweij C.L. Functional analysis of a human tumor necrosis factor α (TNF-α) promoter polymorphism related to joint damage in rheumatoid arthritis. Mol. Med. 4:1998;724-733.
30. Kroeger K.M., Abraham L.J. Identification of an AP-2 element in the -323 to -285 region of the TNF-α gene. Biochem. Mol. Biol. Int. 40:1996;43-51.
31. Louis E., Franchimont D., Piron A., Gevaert Y., Schaaf-Lafontaine N., Roland S., Mahieu P., Malaise M., de Groote D., Louis R., Belaiche J. Tumour necrosis factor (TNF) gene polymorphism influences TNF-α production in lipopolysaccharide (LPS)-stimulated whole blood cell culture in healthy humans. Clin. Exp. Immunol. 113:1998;401-406.
32. McGuire W., Hill A.S.V., Allsop C.E.M., Greenwood B.M., Kwiatkowski D. Variation in the TNF-α promoter region associated with susceptibility to cerebral malaria. Nature. 371:1994;508-511.
33. Mycko M., Kowalski W., Kwinkowski M., Buenafe A.C., Szymanska B., Tronczynska E., Plucienniczak A., Selmaj K. Multiple sclerosis: the frequency of allelic forms of tumor necrosis factor and lymphotoxin-alpha. J. Neuroimmunol. 84:1998;198-206.
34. Nadel S., Newport M.J., Booy R., Levin M. Variation in the tumor necrosis factor-alpha gene promoter region may be associated with death from meningococcal disease. J. Infect. Dis. 174:1996;878-880.
35. Philip R., Epstein L.B. Tumour necrosis factor as immunomodulator and mediator of monocyte cytotoxicity induced by itself, γ-interferon and interleukin-1. Nature. 323:1986;86-89.
36. Pociot F., Wilson A.G., Nerup J., Duff G.W. No independent association between a tumour necrosis factor-alpha promoter region polymorphism and insulin-dependent diabetes mellitus. Eur. J. Immunol. 23:1993;3043-3049.
37. Pociot F., D'Alfonso S., Compasso S., Scorza R., Richiardi P.M. Functional analysis of a new polymorphism in the human TNF alpha gene promoter. Scand. J. Immunol. 42:1995;501-504.
38. Roy S., McGuire W., Mascie-Taylor C.G., Saha B., Hazra S.K., Hill A.V., Kwiatkowski D. Tumor necrosis factor promoter polymorphism and susceptibility to lepromatous leprosy. J. Infect. Dis. 176:1997;530-532.
39. Stuber F., Udalova I.A., Book M., Drutskaya L.N., Kuprash D.V., Turetskaya R.L., Schade F.U., Nedospasov S.A. -308 tumor necrosis factor (TNF) polymorphism is not associated with survival in severe sepsis and is unrelated to lipopolysaccharide inducibility of the human TNF promoter. J. Inflamm. 46:1996;42-50.
40. Turner D.M., Williams D.M., Sankaran D., Lazarus M., Sinnott P.J., Hutchinson IV. An investigation of polymorphism in the interleukin-10 promoter. Eur. J. Immunogen. 24:1997;1-8.
41. Uglialoro A.M., Turbay D., Pesavento P.A., Delgado J.C., McKenzie F.E., Gribben J.G., Hartl D., Yunis E.J., Goldfeld A.E. Identification of three new single nucleotide polymorphisms in the human tumor necrosis factor-α gene promoter. Tissue Antigens. 52:1998;359-367.
42. Verjans G.M., Brinkman B.M., Van Doornik C.E., Kijlstra A., Verweij C.L. Polymorphism of tumour necrosis factor-alpha (TNF-alpha) at position -308 in relation to ankylosing spondylitis. Clin. Exp. Immunol. 97:1994;45-47.
43. Vinasco J., Beraun Y., Nieto A., Fraile A., Mataran L., Pareja E., Martin J. Polymorphism at the TNF loci in rheumatoid arthritis. Tissue Antigens. 49:1997;74-78.
44. Walley A.J., Cookson W.O. Investigation of an interleukin-4 promoter polymorphism for associations with asthma and atopy. J. Med. Genet. 33:1996;689-692.
45. Weinshenker B.G., Wingerchuk D.M., Liu Q., Bissonet A.S., Schaid D.J., Sommer S.S. Genetic variation in the tumor necrosis factor alpha gene and the outcome of multiple sclerosis. Neurology. 49:1997;378-385.
46. Westendorp R.G.J., Langermans J.A.M., Huizinga T.W.J., Elouali A.H., Verweij C.L., Boomsma D.I., Vandenbrouke J.P. Genetic influence of cytokine production and fatal meningococcal disease. Lancet. 349:1997;170-173.
47. Wilson A.G., Di Giovine F.S., Blakemore A.I., Duff G.W. Single base polymorphism in the human tumour necrosis factor alpha (TNF alpha) gene detectable by NcoI restriction of PCR product. Hum. Mol. Genet. 1:1992;353.
48. Wilson A.G., de Vries F.S., Pociot F., di Giovine F.S., van der Putte L.B.A., Duff G.W. An allelic polymorphism within the human tumor necrosis factor alpha promoter region is strongly associated with HLA A1, B8, and DR3 alleles. J. Exp. Med. 177:1993;557-560.
49. Wilson A.G., Di Giovine F.S., Duff G.W. Genetics of tumour necrosis factor-alpha in autoimmune, infectious and neoplastic diseases. J. Inflamm. 45:1995;1-12.
50. Wilson A.G., de Vries N., van de Putte L.B., Duff G.W. A tumour necrosis factor alpha polymorphism is not associated with rheumatoid arthritis. Ann. Rheum. Dis. 54:1995;601-603.
51. Wilson A.G., Symons J.A., McDowell T.L., McDevitt H.O., Duff G.W. Effects of a polymorphism in the human tumour necrosis factor α promoter on transcriptional activation. Proc. Natl. Acad. Sci. USA. 94:1997;3195-3199.
52. Wingerchuk D., Liu Q., Sobell J., Somer S., Weinshenker B.G. A population-based case-control study of the tumor necrosis factor alpha-308 polymorphism in multiple sclerosis. Neurology. 49:1997;626-628.
53. Zimmerman P.A., Guderian R.H., Nutman T.B. A new TNFA promoter allele identified in South American Blacks. Immunogenetics. 44:1996;485-486.